Drug intelligence / Profile preview

Perfectha Derm Lidocaine

Development stage
Unknown
Lead developer
Sinclair
Administration
Intradermal
01

Overview

Perfectha Derm Lidocaine is a cross-linked hyaluronic acid-based injectable dermal filler developed by Sinclair Pharma. It is formulated with 20 mg/mL of cross-linked sodium hyaluronate and 0.3% lidocaine hydrochloride, which serves as a local anesthetic to enhance patient comfort during administration. As a dermal filler, it is primarily indicated for the correction of medium to deep facial wrinkles and skin depressions, such as nasolabial folds and marionette lines, as well as for lip volume augmentation and contour definition. The gel works by integrating into the extracellular matrix, where the hyaluronic acid binds water to restore tissue structure and provide physical volumization. It is CE-marked as a medical device and is typically administered via intradermal injection by healthcare professionals, with effects reported to last between 9 and 12 months.

Brand names
Perfectha Derm LidocainePerfectha Derm
Other names
Perfectha Derm with Lidocaine
02

Targets

NaV (Voltage-gated sodium channels)CD44 (CD44 antigen)

Beyond the preview

Go deeper on Perfectha Derm Lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perfectha Derm Lidocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call